Combination therapy with an Xa inhibitor and antihypertensive agent improved anticoagulant activity in patients with nonvalvular atrial fibrillation: the hypertension and atrial fibrillation treated by rivaroxaban for the morning and night with sYnergy with calcium antagonists (HARMONY) study.

Conclusions: Xa inhibitor therapy improved anticoagulant activity, and additional antihypertensive therapy maintained the anticoagulant activity in patients with nonvalvular AF. PMID: 31542950 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31542950?dopt=Abstract

Source: Clinical and Experimental Hypertension - September 20, 2019 Category: Cardiology Authors: Kabutoya T, Ohmori T, Fujiwara T, Kario K Tags: Clin Exp Hypertens Source Type: research